Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Insulin biosimilars Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Diabetes Devices Market - 2025-2033
... the medical devices used to manage and monitor diabetes. These devices help individuals with diabetes control their blood glucose levels, deliver insulin and improve overall management of the condition, thus reducing the risks of complications ... Read More
-
Europe Diabetic Foot Ulcers Market- 2023-2030
... and is a critical health regard worldwide. Diabetic foot ulcers are thickened wounds below the ankle. It is generated by irritated or wounded feet due to nominal trauma or pressure, neuropathic and vascular changes, poor ... Read More
-
Global Diabetic Neuropathy Market 2023-2030
... to exhibit a CAGR of 6.7% during the forecast period (2024-2031). Diabetic neuropathy can be autonomic neuropathy, proximal neuropathy, focal neuropathy, and peripheral neuropathy. The growing market developments and increasing cases of diabetes among other ... Read More
-
Global Glucose Monitoring Device Market - 2024 - 2031
... East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031 Global Glucose Monitoring Devices market is estimated to grow at a CAGR of 10.5% during the forecast period 2024-2031 A glucose meter, often known ... Read More
-
Innovations and Growth Opportunities in Electroceuticals for Chronic Diseases
... to revolutionize the field, creating promising opportunities for technology developers in the electroceutical industry for product development. However, the innovations face significant challenges, including non-selectivity, invasiveness, open-loop, and risk of data breach. As a result, ... Read More
-
Mail Order Pharmacy Global Market Opportunities And Strategies To 2034 Including: 1) By Product Type: Dermal Care; Diabetes; Cardiovascular Medicines; Blood Pressure; Asthma; Cold And Flu; Painkillers 2) By Drug Type: Non-Prescription Drugs; Prescription Drugs 3) By Mode Of Order: Online Store; Pharmacy App Covering: CVS Health Corporation; Wal-Mart Stores Inc. (Walmart Pharmacy); Kroger Health; Cardinal Health Inc.; Humana Pharmacy Solutions Inc.
... market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how the market is being ... Read More
-
2025 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with Updated Analysis & Forecasts
... & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling endocrine, nutritional ... Read More
-
Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030
... patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death ... Read More
-
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-Like Peptide-1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase) - Global Forecast to 2030
... age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role ... Read More
-
Global Type 2 Diabetes Market 2025-2029
... 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
North America Hemodynamic Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... The COVID-19 pandemic significantly impacted the North American hemodynamic monitoring market. Patients with COVID-19 respiratory failure showed a marked rise in blood pressure over time, not accompanied by distinctive markers of circulatory failure. For instance, ... Read More
-
Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030
... rapidly expanding due to a variety of factors such as advancement in telecommunication technologies, government support and regulatory policies, and expansion of remote patient moniytoring systems. An aging population necessitates continuous monitoring of chronic conditions, ... Read More
-
Rare Endocrine Disease Treatment
... 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Acromegaly Indication, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.7 Billion by the ... Read More
-
Injection Pens
... CAGR of 5.9% over the analysis period 2024-2030. Disposable Injection Pens, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the ... Read More
-
Diabetes Injection Pens
... at a CAGR of 5.7% over the analysis period 2024-2030. Insulin Pens, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$8.2 Billion by the end of ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution Form, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Diabetic Foot Ulcers and Pressure Ulcers
... reach US$6.0 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Diabetic Foot Ulcers, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and ... Read More
-
Insulin Pen Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Standard Insulin Pen Needles, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the ... Read More
-
Metabolic Health
... cutting-edge products designed to optimize energy levels and support a healthier lifestyle. It will include expert insights on how diet, exercise, and sleep impact metabolic health to the newest research on food supplements and interventions. Read More
-
Digital Diabetes Management
... at a CAGR of 18.6% over the analysis period 2024-2030. Digital Diabetes Devices, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$46.7 Billion by the end ... Read More
-
Insulin Patch Pumps
... at a CAGR of 9.8% over the analysis period 2024-2030. Basal & Bolus Delivery, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$1.4 Billion by the ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$996.0 Million by the end ... Read More
-
Blood Glucose Monitoring Systems
... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring Systems, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the ... Read More
-
Human Insulin
... CAGR of 6.8% over the analysis period 2024-2030. HI Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$70.6 Billion by the end of the analysis ... Read More
Research Assistance
